130 related articles for article (PubMed ID: 33714521)
21. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic astrocytoma.
Grimm SA; Chamberlain MC
CNS Oncol; 2016 Jul; 5(3):145-57. PubMed ID: 27230974
[TBL] [Abstract][Full Text] [Related]
23. Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma.
Galanis E; Wen PY; de Groot JF; Weller M
Hematol Oncol Clin North Am; 2022 Feb; 36(1):113-132. PubMed ID: 34756799
[TBL] [Abstract][Full Text] [Related]
24. Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.
Shimizu T; Matsushima S; Fukasawa N; Akasaki Y; Mori R; Ojiri H
J Clin Neurosci; 2020 Jun; 76():140-144. PubMed ID: 32291242
[TBL] [Abstract][Full Text] [Related]
25. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R;
Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067
[TBL] [Abstract][Full Text] [Related]
26. Magnetic Resonance Imaging Reveals a Pronounced Treatment Response of a Isocitrate Dehydrogenase- and B-Raf Proto-Oncogene-Wildtype Epithelioid Glioblastoma.
Werner JM; Brunn A; Fink GR; Galldiks N
World Neurosurg; 2019 Jul; 127():213-215. PubMed ID: 30974270
[TBL] [Abstract][Full Text] [Related]
27. Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H Mutation.
Tourne M; Tauziède-Espariat A; Dezamis E; Saffroy R; Dhermain F; Chrétien F; Varlet P
World Neurosurg; 2018 Aug; 116():316-321. PubMed ID: 29859360
[TBL] [Abstract][Full Text] [Related]
28. Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review.
Lee D; Riestenberg RA; Haskell-Mendoza A; Bloch O
J Neurooncol; 2021 Mar; 152(1):89-98. PubMed ID: 33389563
[TBL] [Abstract][Full Text] [Related]
29. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
Stichel D; Ebrahimi A; Reuss D; Schrimpf D; Ono T; Shirahata M; Reifenberger G; Weller M; Hänggi D; Wick W; Herold-Mende C; Westphal M; Brandner S; Pfister SM; Capper D; Sahm F; von Deimling A
Acta Neuropathol; 2018 Nov; 136(5):793-803. PubMed ID: 30187121
[TBL] [Abstract][Full Text] [Related]
30. Presurgical integrated MRI/SPECT localization of the sensorimotor cortex in a patient with a low-grade astrocytoma in the rolandic area.
Sabatini U; Pantano P; Brughitta G; Celli P; Ricci M; Lenzi G; Bozzao L
Neuroreport; 1995 Dec; 7(1):105-8. PubMed ID: 8742428
[TBL] [Abstract][Full Text] [Related]
31. Integrated molecular characterization of IDH-mutant glioblastomas.
Korshunov A; Casalini B; Chavez L; Hielscher T; Sill M; Ryzhova M; Sharma T; Schrimpf D; Stichel D; Capper D; Reuss DE; Sturm D; Absalyamova O; Golanov A; Lambo S; Bewerunge-Hudler M; Lichter P; Herold-Mende C; Wick W; Pfister SM; Kool M; Jones DTW; von Deimling A; Sahm F
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):108-118. PubMed ID: 30326163
[TBL] [Abstract][Full Text] [Related]
32. IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome.
Moriya K; Kaneko MK; Liu X; Hosaka M; Fujishima F; Sakuma J; Ogasawara S; Watanabe M; Sasahara Y; Kure S; Kato Y
Cancer Sci; 2014 Mar; 105(3):359-62. PubMed ID: 24344754
[TBL] [Abstract][Full Text] [Related]
33. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
[TBL] [Abstract][Full Text] [Related]
34. IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?
Labussiere M; Sanson M; Idbaih A; Delattre JY
Oncologist; 2010; 15(2):196-9. PubMed ID: 20133500
[TBL] [Abstract][Full Text] [Related]
35. T
Kinoshita M; Uchikoshi M; Sakai M; Kanemura Y; Kishima H; Nakanishi K
Magn Reson Med Sci; 2021 Mar; 20(1):119-123. PubMed ID: 32101817
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment for pure aqueductal tumor.
Tamura R; Miwa T; Ohira T; Yoshida K
J Clin Neurosci; 2017 Oct; 44():260-263. PubMed ID: 28690017
[TBL] [Abstract][Full Text] [Related]
37. The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas.
Christians A; Adel-Horowski A; Banan R; Lehmann U; Bartels S; Behling F; Barrantes-Freer A; Stadelmann C; Rohde V; Stockhammer F; Hartmann C
Acta Neuropathol Commun; 2019 Oct; 7(1):156. PubMed ID: 31623667
[TBL] [Abstract][Full Text] [Related]
38. Freiburg Neuropathology Case Conference : Contrast-enhancing Brain Lesion 6 Months after Resection and Combined Radiotherapy and Chemotherapy of an Unmethylated but IDH R132H-mutated Glioblastoma Multiforme.
Demerath T; Erny D; Schnell O; Urbach H; Prinz M; Taschner CA
Clin Neuroradiol; 2021 Mar; 31(1):283-288. PubMed ID: 33625551
[No Abstract] [Full Text] [Related]
39. Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.
Zhang Z; Chan AK; Ding X; Li Y; Zhang R; Chen L; Liu Y; Wang Y; Xiong J; Ng HK; Yao Y; Zhou L
Neuro Oncol; 2017 Jul; 19(7):1008-1010. PubMed ID: 28874004
[No Abstract] [Full Text] [Related]
40. Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma.
Li M; Ren X; Chen X; Wang J; Shen S; Jiang H; Yang C; Zhao X; Zhu Q; Cui Y; Lin S
Eur Radiol; 2022 Jun; 32(6):3869-3879. PubMed ID: 35079884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
